Nudging Patients to Increase Shingles Vaccination

Launched by GEISINGER CLINIC · Jan 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying ways to encourage more people to get the Shingrix vaccine, which helps prevent shingles, a painful rash that can happen later in life. Researchers want to see if sending messages to patients, reminding them to ask about the vaccine during their doctor appointments, can increase the number of vaccinations. They will also compare different types of messages to find out which one works best.

To join the study, participants need to be 50 years or older and should not have received any doses of the Shingrix vaccine before. They must have a scheduled in-person appointment at a Geisinger primary care location that offers the vaccine. If you qualify and choose to participate, you’ll receive a reminder message before your appointment. This study is currently looking for participants, and it's a great opportunity to help improve vaccination rates for shingles in the community!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 50+
• • Has not received any doses of the Shingrix vaccine according to the Geisinger EHR
• • Has a non-acute in-person Geisinger primary care appointment in a department that stocks Shingrix scheduled with enough time to be randomized
• Exclusion Criteria:
• • Cannot be contacted via the communication modality being used in the study (e.g., patient portal, SMS), e.g., due to insufficient/missing contact information in the EHR or because they opted out
• • Patient does not have an approved insurance on file for Shingrix outreach for their appointment type or department
• • Appointment type or department not approved for outreach by Geisinger leadership at the time of outreach
• • While a separate flu vaccination nudge campaign is running (approximately from September through December, 2024), patients will be excluded if they have not received a flu shot in the 2024-25 flu season according to the EHR. Such patients will be eligible for inclusion again as soon as the flu vaccination campaign ends.